Senti Biosciences, Inc.
Senti Biosciences, Inc., a pioneering entity in the synthetic biology sector, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a leader in developing advanced gene circuits and cell therapies, focusing on innovative solutions for complex diseases. Senti's core offerings include engineered cell therapies that leverage cutting-edge synthetic biology techniques, setting them apart in a competitive market. The company’s unique approach to programmable cell therapies has garnered attention for its potential to revolutionise treatment paradigms in oncology and other therapeutic areas. With a strong emphasis on research and development, Senti Biosciences has achieved significant milestones, positioning itself as a notable player in the biotechnology landscape. Its commitment to advancing the field of synthetic biology continues to drive its growth and influence within the industry.
DitchCarbon Score
How does Senti Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Senti Biosciences, Inc.'s score of 18 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Senti Biosciences, Inc.'s reported carbon emissions
Senti Biosciences, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete emissions figures or defined reduction strategies, it is challenging to assess their environmental impact or commitment to climate action. However, the absence of data may indicate a need for further transparency in their sustainability practices. As the biotechnology industry increasingly prioritises climate responsibility, Senti Biosciences may benefit from establishing clear emissions reporting and reduction goals to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Senti Biosciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
